Allianz Asset Management’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Allianz Asset Management’s Portfolio MBII Stock Details MBII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,000,928	Closed	-$1.16M	–	2221
2022 Q2	$1.16M	Hold	1,000,928	–	–	﹤0.01%	1627
2022 Q1	$1.08M	Hold	1,000,928	–	–	﹤0.01%	1833
2021 Q4	$721K	Sell	1,000,928 -126,939	-11%	-$103K	﹤0.01%	2045
2021 Q3	$1.02M	Sell	1,127,867 -597,075	-35%	-$719K	﹤0.01%	1925
2021 Q2	$2.86M	Buy	1,724,942 +181,196	+12%	+$303K	﹤0.01%	1342
2021 Q1	$3.23M	Buy	+1,543,746	New	+$3.21M	﹤0.01%	1233

Allianz Asset Management's MBII Position: Q3 2022 in Review

Allianz Asset Management sold out of Marrone Bio Innovations, Inc. (MBII) in Q3 2022, closing a stake of 1,000,928 shares — an estimated $1.16M sold.

Allianz Asset Management first reported a position in MBII in Q1 2021 and held it in 6 quarters. The position peaked at $3.23M in Q1 2021. 0 funds tracked by Wall St. Rank hold MBII as of Q3 2022.

Allianz Asset Management reported no remaining Marrone Bio Innovations, Inc. position as of Q3 2022 after selling out during the quarter.
Allianz Asset Management sold 1,000,928 Marrone Bio Innovations, Inc. shares in Q3 2022, an estimated $1.16M.
Allianz Asset Management first reported a position in Marrone Bio Innovations, Inc. in Q1 2021 and held it in 6 quarters.
Allianz Asset Management's Marrone Bio Innovations, Inc. position peaked at $3.23M in Q1 2021.
0 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2022.

Based on Allianz Asset Management's 13F filing for Q3 2022, filed 8 Nov 2022.